Login to Your Account

U.S. Patent Disclosures

Tuesday, August 14, 2012
• Neuralstem Inc., of Rockville, Md., has been issued U.S. Patent No. 12/710,097, "Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions." The patent covers the process of culturing central nervous system cells and transplanting them into spinal cord tissue to treat neurodegenerative disorders, such as amytrophic lateral sclerosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription